Thursday, August 2, 2012

One year’s preventive therapy reduces the risk of TB in people on HIV treatment

Image: WHO/TBP/Gary Hampton
Twelve months of isoniazid (INH) preventive therapy (IPT) significantly reduced the incidence of all TB diagnoses in people with HIV who are also on antiretroviral therapy (ART), according to large randomised study conducted in Khayelitsha, South Africa.
“There was a 37% reduction in the rate of incident TB in the INH treatment group compared to those who were receiving ART alone,” said Dr Molebogeng Xheedhe Rangaka of the University of Cape Town, who presented the study findings.
This was a ‘late breaker’ at the conference and a full news story will be published on aidsmap tomorrow.

No comments: